Selective Antioxidant

Not Every Free Radical Is Your Enemy

If you have read anything about antioxidants in the last thirty years, you have been told the same story: free radicals are bad, antioxidants destroy free radicals, therefore more antioxidants is better.

That story is roughly half right, and the half it gets wrong is the interesting half.

Your body produces several different reactive molecules, and it does not produce them by accident. Some of them are signals. Nitric oxide helps regulate blood vessel tone. Hydrogen peroxide acts as a messenger between cells. Superoxide is part of how your immune cells do their job. These are not damage. These are function.

And then there is the hydroxyl radical, which is pure damage and nothing else.

So the honest question is not whether a substance is an antioxidant. Nearly anything can be. The honest question is whether it can tell the difference between the molecule doing harm and the molecule doing work.

That question is the reason hydrogen has been studied the way it has since 2007, and it is the one thing about hydrogen water that genuinely sets it apart from a vitamin C tablet.

The Problem With Mopping Up Everything

A broad antioxidant does not aim. It reacts with whatever reactive molecule it encounters, which sounds like an advantage until you remember that some of those molecules were carrying a message.

This is not a fringe concern. It is one of the standing puzzles in the field: large trials of high-dose antioxidant supplements have repeatedly failed to produce the benefits that the laboratory work predicted, and in some cases the supplemented groups did worse than the people taking nothing. Researchers have spent years arguing about why.

One of the leading explanations is exactly the problem described above. If you flood the system with something that neutralizes reactive molecules indiscriminately, you interfere with signalling your cells were relying on. You have not fixed the damage. You have jammed the switchboard.

That is a chemistry problem, not a marketing problem. And in 2007, a Japanese research group published a paper arguing that molecular hydrogen solves it.

The One That Does the Damage

The hydroxyl radical is in a category of its own.

Most reactive molecules in the body are selective to some degree — they react with certain things and not others, which is what makes signalling possible in the first place. The hydroxyl radical is not selective at all. It reacts with essentially the first molecule it meets, at close to the speed at which the two can collide.

That has two consequences.

So the hydroxyl radical is both the most destructive reactive molecule your body produces and the one it has the least defence against. Research suggests that is the gap molecular hydrogen fits into.

The 2007 Finding

In 2007, Ohsawa and colleagues published a paper in Nature Medicine reporting that molecular hydrogen reacts with the hydroxyl radical and with peroxynitrite, and does not appreciably react with superoxide, hydrogen peroxide, or nitric oxide at the concentrations found in the body.

If that holds, it is the whole argument in one sentence: hydrogen reacts with the two molecules that cause damage and leaves the three that carry signals intact.

That paper is the reason this field exists. The 40 studies catalogued in this section of our references were published between 2007 and 2015, and almost all of them are follow-on work asking whether the selectivity reported in 2007 shows up in living tissue under oxidative stress.

It is worth being precise about what the selectivity claim is and is not. It is a statement about reaction chemistry — which molecules hydrogen interacts with under physiological conditions. It is not a statement that hydrogen produces a particular health outcome in a person. Those are two different claims requiring two different kinds of evidence, and a later section is about the difference.

Why Size Comes Into It

Selectivity is only useful if the molecule can reach the place where the damage happens.

This is the second half of the mechanism argument, and it is simple physics. Molecular hydrogen is the smallest molecule in existence. It carries no charge and it is not water-soluble in the way most antioxidants are, which means research suggests it passes through cell membranes by simple diffusion rather than needing a transporter to carry it.

That matters because the hydroxyl radical is produced inside cells, including inside mitochondria. A large, charged antioxidant molecule circulating in the bloodstream is not necessarily anywhere near it.

Researchers studying hydrogen have consistently pointed to this as the practical advantage: a molecule that is both selective and small enough to go where the reaction is. Vitamin C is neither. Vitamin E is fat-soluble and sits in membranes, but it is not selective.

None of this requires exotic chemistry to believe. Hydrogen's size and diffusivity are established physical properties, documented in reference physical-chemistry data rather than in anyone's product literature (Chemistry studies 132 to 154).

What This Research Is, and What It Is Not

This is the part that makes the rest believable, and it is also the part that keeps us honest about a body of research that is frequently overstated.

What to Take From It

So where does that leave someone deciding whether hydrogen water is worth it?

With a mechanism that is well characterised and a set of outcomes that is not. That is an honest place to be, and it is more than most things on the shelf can say.

So the useful question to ask a hydrogen water company is not what it will do for you — anyone willing to answer that is telling you something they cannot back. The useful question is how much hydrogen is in the water, and how they measured it. That number is testable, and a company that has done the chemistry can give it to you.

Ask us. We will tell you what is in ours, and what the research does and does not say about it.

Educational information only. Not intended to diagnose, treat, cure, or prevent any disease. Consult your doctor.

References

Study numbers follow the Ischemia/Reperfusion Injuries section of lifeionizers.com/pages/studies, numbers 298 to 337. The foundational selectivity paper sits in the Antioxidant section of the same page. The table is grouped by how hydrogen was delivered, because that is the detail that decides what each study can and cannot be cited for.

Key papers by name